Online Media Kit


January 26, 2021 | World Health Organization

WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection

WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »


November 30, 2020 | New York Times

Berry-Flavored H.I.V. Medication Is Ready for Babies

The World Health Organization approved the dapivirine ring, a vaginal insert that has proved effective in women who use it consistently. Finding prevention methods that women can use discreetly has... More »


July 30, 2020 | Aidsmap (UK)

The vaginal ring against HIV: regulatory approval for a new prevention choice for women

The dapivirine ring is the first HIV prevention option specifically designed for women since the female condom was approved nearly 30 years ago. More »


July 24, 2020 | Times LIVE (South Africa)

Vaginal ring gives women more options for HIV prevention

Access to a long-acting vaginal ring, which was tested in SA and showed promising results, is getting closer to reality after Europe’s regulatory body gave it the thumbs-up. More »

Media Highlights

August 05, 2020 | El País (Spain)

La Agencia Europea del Medicamento da el visto bueno a un anillo vaginal para prevenir el VIH

The EMA gave a positive scientific opinion for the dapivirine ring. More »

August 03, 2020 | East Coast Radio (South Africa)

New HIV prevention tool yields positive feedback

The South African National AIDS Council (SANAC) says an antiretroviral ring, approved by the European Medicines Agency recently, will empower women to protect themselves against HIV.  More »

August 03, 2020 | Consultor Salud (Colombia)

Dapivirina, un anillo vaginal que podria prevenir el VIH en mujeres

The EMA has indicated that when PrEP is not used, cannot be used or is not available, it may become an option as the ring is placed in the vagina and slowly releases dapivirine for 28 days. More »

August 01, 2020 | The Herald (Zimbabwe)

Zim to register new HIV prevention intervention

The EMA has acceded to the use of an antiretroviral drug dapivirine through a vaginal ring to prevent HIV acquisition by women. More »

July 31, 2020 | El Espectador (Colombia)

Anillos vaginales, ¿cómo aumentarían las opciones de prevención del VIH en las mujeres?

(Via SINC) IPM's Bríd Devlin on the next steps for the dapivirine ring following the EMA's positive opinion. More »